Prognostic possibilities of neurophysiological methods of examination in diagnostics and treatment of preliminary ejaculation


Cite item

Full Text

Abstract

Premature ejaculation (PE) is the most common male sexual disorder. The results of the study, including 55 men with PE and 30 healthy volunteers, whose goal was to define the role of somatosensory evoked potential (SEP) in the differential diagnosis of different forms of PE and predicting the effectiveness of treatment with selective serotonin reuptake inhibitors (SSRIs) in this category of patients are presented. At the stage of primary ambulation, the SEP evaluation is also allow to perform differential diagnosis between primary and secondary forms of PE. This will optimize the algorithm of examination and treatment of this category of patients. The subsequent SSRIs administration are clinically effective in patients who respond to the test with paroxetine, which also plays an important role in the choice of treatment.

References

  1. McMahon CG. Long term results of treatment of premature ejaculation with selective serotonin reuptake inhibitors. Int J Imp Res 2002;14(Suppl. 3):S19.
  2. Waldinger MD. The neurobiological approach to premature ejculatuon. J Urol 2002;168(6):2359-67.
  3. Patrick D, Althof S, Pryor J, et al. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005;2:358-67.
  4. Xin ZC, Choi YD, Rha KH, et al. Somatosensory evoked potentials in patients with premature ejaculation. J Urol 1997;158:451-55.
  5. Сегал А.С., Пушкарь Д.Ю. Преждевременная эякуляция: определение, рабочая классификация, алгоритм обследования больных и результаты их использования // Урология. 2006. № 3. С. 66-69.
  6. Sotomayor M. The burden of premature ejaculation: The patient's perspective. J Sex Med 2005;2(Suppl. 2):110-14.
  7. Porst H, Buvat J. (eds.) Standard practice in sexual medicine. Oxford, Blackwell Publishing 2006.
  8. Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 2006;3(Suppl. 4):303-08.
  9. Benson GS. Erection, emission and ejaculation: Physiologic mechanisms. In Lipshultz L.I, Howards S.S. (eds) Infertiliti in the Male, ed 3. St.Louis, Mosby. 1997:155.
  10. Perretti A, Catalano A, Mirone V, et al. Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. Urulogy 2003;61:623-28.
  11. McMahon CG, Stuckey B, Andersen ML. Efficacy of viagra: sildenafil citrate in men with premature ejaculation. J Sex Med 2005;2(3):368.
  12. Chen J, Kern-Paz G, Bar-Yoser Y, et al. The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data. Eur Urol 2007;52:1331-39.
  13. Waldinger M. Towards evidenced based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impotence Res 2003;15(5):309-13.
  14. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 1999;161(6):1826-30.
  15. Strassberg DS, de Gouveia Brazao CA, Rowland DL, et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999;25(2):89-101.
  16. Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology 1999;54(3):544-47.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies